Skip to main content
Signal8

AVAI BIO, INC. (AVAI)

Avai Bio, Inc. operates as a holding company primarily focused on creating websites and mobile applications that offer users personalized and convenient experiences. Its business activities include providing IT consulting services and making artificial intelligence accessible to the general public. The company was established on November 6, 2017, and its main office is situated in Las Vegas, Nevada.

Sector: Services-Computer Processing & Data Preparation

Industry: Software - Application

Avai Bio, Inc. logo

Avai Bio, Inc.

OTC:AVAITechnology
+3.00%$0.0927
Mkt Cap$14.27M
Float139.32M
O/S153.92M
Inst Own-
SI<0.1%
Dilution
FormDescription
10-Q
10-K
REPORT 10-K
NT 10-K
NOTIFICATION OF LATE FILING
2
8-K
1.01,9.01
10-Q
REPORT 10-Q
8-K
8.01,9.01
10-Q
REPORT 10-Q
8-K
1.01,9.01
8-K
1.01,9.01
8-K
8.01
10-Q
REPORT 10-Q
10-K
REPORT 10-K
NT 10-K
NOTIFICATION OF LATE FILING
8-K
1.02,9.01
RW
WITHDRAWAL REQUEST
S-1/A
Registration Statement (Amended)
S-1
Registration Statement
8-K
1.01,9.01
UPLOAD
SEC Filing
10-K/A
Annual Report (Amended)
10-Q
Quarterly Report
UPLOAD
SEC Filing
CORRESP
SEC Filing
10-Q/A
Quarterly Report (Amended)
10-Q/A
Quarterly Report (Amended)

1-25 of 117

    AVAI BIO, INC. (AVAI) SEC Filings: 10-K, 10-Q, 8-K, Form 4 | Signal8